Bala

Exploring Adverse Events

Occupational and Accidental Exposure: An Adverse Event

In this article, we address more complex special case scenarios, such as occupational and accidental exposures, when reported as adverse events.

Bala

Read

MedDRA Series

MedDRA Coding: Core Principles Explained

n this MedDRA series article, we will explore additional tips to help enhance your case processing skills, particularly for those who may feel uncertain about MedDRA coding.

Bala

Read

ICSR Management

Case Merging: Key Concepts and Criteria Explained

This blog covers: Introduction In this comprehensive blog, we will delve into the nuances and criteria that determine…

Bala

Read

ICSR Management

Mastering Duplicate Detection: Your Ultimate Guide

In this detailed blog, we delve into the detection of duplicates in pharmacovigilance case processing, incorporating statistical insights throughout our exploration. Join us on our journey as we share our findings and insights.

Bala

Read

ICSR Management

Understanding Duplicates in Pharmacovigilance

This blog covers: Introduction Duplicate reports are a regular challenge in pharmacovigilance case processing, encountered by professionals. This…

Bala

Read

ICSR Management

Pregnancy cases in PV: An overview

In this comprehensive blog, you will explore the various categories and scenarios involved in handling pregnancy cases within pharmacovigilance case processing. Let’s dive in!

Bala

Read

ICSR Management

101: Effective Case Book-in Pharmacovigilance: A Step-by-Step Guide 🎟️

Here in this informative pharmacovigilance blog, where we provide a comprehensive overview of the book-in process in Individual Case Safety Report (ICSR) management. In this article, we present a step-by-step guide that simplifies the book-in process, ensuring a better understanding for all.

Bala

Read

Drug safety and pharmacovigilance

Decoding Personal Data in Pharmacovigilance Reporting

In this comprehensive blog, you’ll learn everything about handling personal data within pharmacovigilance reporting, along with crucial insights. Stay tuned for more updates!

Bala

Read